ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,021Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1749

$1.33M Total Retail Price of All Prescriptions

Rank: 26 out of 1749

438 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

6% of this provider’s 3,271 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$133 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
RISPERIDONE 789 316 1 1
ZOLPIDEM TARTRATE 409 147 2 9
TRAZODONE HCL 384 149 3 2
QUETIAPINE FUMARATE 357 103 4 4
ABILIFY 326 121 5 5
BENZTROPINE MESYLATE 290 43 R 6 3
CLOZAPINE 282 26 7 11
DIVALPROEX SODIUM 280 71 8 15
TOPIRAMATE 278 69 9 29
PAROXETINE HCL 247 139 10 19
OLANZAPINE 240 72 11 6
GABAPENTIN 230 51 12 27
MIRTAZAPINE 210 94 13 16
VENLAFAXINE HCL ER 182 60 14 17
SEROQUEL 172 69 15 24
SERTRALINE HCL 167 57 16 7
FLUOXETINE HCL 160 26 17 8
SEROQUEL XR 145 53 18 25
TRIHEXYPHENIDYL HCL 140 45 R 19 33
CYMBALTA 138 59 20 12
FLUVOXAMINE MALEATE 136 61 21 54
CITALOPRAM HBR 134 38 22 10
DONEPEZIL HCL 130 119 23 30
PANTOPRAZOLE SODIUM 124 0 24 111
ESCITALOPRAM OXALATE 118 21 25 23
DIVALPROEX SODIUM ER 112 45 26 13
LITHIUM CARBONATE 102 42 27 20
BUPROPION XL 100 0 28 18
LAMOTRIGINE 99 33 29 14
SAPHRIS 92 27 30 56
IBUPROFEN 89 0 31 114
HALOPERIDOL 87 17 32 21
VIIBRYD 76 17 33 66
LEVETIRACETAM 74 23 34 91
AMITRIPTYLINE HCL 74 37 R 34 47
LEXAPRO 70 35 36 38
NAMENDA 68 68 37 31
FLUPHENAZINE DECANOATE 68 0 37 79
ATENOLOL 67 20 39 83
HALOPERIDOL DECANOATE 63 0 40 50
LEVOTHYROXINE SODIUM 62 0 41 37
DOXEPIN HCL 62 40 41 64
OLANZAPINE ODT 60 23 43 40
AMLODIPINE BESYLATE 56 13 44 82
MEGESTROL ACETATE 55 30 R 45 106
PRISTIQ ER 54 0 46 49
BUPROPION HCL SR 51 14 47 22
RISPERDAL CONSTA 51 38 47 42
CARBAMAZEPINE 51 20 47 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.